Tet Yap, Nicholas Watkin, Suks Minhas European Urology Supplements

Slides:

Advertisements

Similar presentations

Pascal Rischmann European Urology Supplements

Advertisements

Prostate Cancer 2008: Challenges in Diagnosis and Management

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Management of Acute and Chronic Retention in Men

Robotic Cystectomy Versus Open Cystectomy: Are We There Yet?

Volume 63, Issue 4, Pages (April 2013)

Volume 58, Issue 5, Pages (November 2010)

Shock Wave Lithotripsy for Renal and Ureteric Stones

The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy Olaf A. Brinkmann,

Bladder Cancer: Management and Future Directions

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Prostate Cancer Epidemic in Sight?

Shock Wave Lithotripsy for Renal and Ureteric Stones

Martin C. Michel European Urology Supplements

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Bladder Cancer: A Major Public Health Issue

What is New in Bladder Cancer Diagnosis and Management?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Back to the Future: Introduction and Conclusions

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Prostate Cancer Epidemic in Sight?

Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy Kerstin Junker, Sebastian Hölters,

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

An Update of Current Practice in Hypospadias Surgery

Glycosaminoglycan Therapy for Bladder Diseases: Emerging New Treatments Pier Francesco Bassi, Elisabetta Costantini, Steve Foley, Stefano Palea European.

Richard C. Harkaway European Urology Supplements

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

The Importance of Testosterone Control in Prostate Cancer

Jacques Irani European Urology Supplements

Optimal Testosterone Control and Eligard®

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Impact of Tamsulosin OCAS on Energy of Patients with LUTS/BPH

Long-Term Hormonal Therapy: Who Would Benefit?

Sergio Bracarda European Urology Supplements

Pharmacotherapy in Stress and Mixed Incontinence

Christian Stief European Urology Supplements

Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma Fred Saad European Urology.

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Who Forms Stones and Why?

Prostate Cancer 2008: Challenges in Diagnosis and Management

Martin Michel, Jean de la Rosette European Urology Supplements

Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer P. Mongiat-Artus, P. Teillac

Richard Berges European Urology Supplements

Improving Flexibility and Quality of Life for Your Patients: A Must?

Profile of Silodosin European Urology Supplements

Robotic Cystectomy Versus Open Cystectomy: Are We There Yet?

Reducing antibiotic use in influenza: challenges and rewards

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis

The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients Kurt Miller European Urology Supplements Volume.

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Testim® Gel: Review of Clinical Data

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Diagnosis and Management of Cryptorchidism

New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer Noel W. Clarke European Urology Supplements

Jan Roigas European Urology Supplements

Volume 51, Issue 5, Pages (May 2007)

Michael Marberger European Urology Supplements

Introduction European Urology Supplements

Presentation transcript:

Infections of the Genital Tract: Human Papillomavirus–Related Infections Tet Yap, Nicholas Watkin, Suks Minhas European Urology Supplements Volume 16, Issue 4, Pages 149-162 (April 2017) DOI: 10.1016/j.eursup.2016.08.005 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Transmission electron micrograph of the human papillomavirus structure. Reproduced from the Laboratory of Tumor Virus Biology with permission from the National Cancer Institute [125]. European Urology Supplements 2017 16, 149-162DOI: (10.1016/j.eursup.2016.08.005) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Genital warts. Photograph courtesy of Cathy Corbishley, St George's Hospital, London, UK. European Urology Supplements 2017 16, 149-162DOI: (10.1016/j.eursup.2016.08.005) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 3 Warty penile carcinoma. Photograph courtesy of Cathy Corbishley, St George's Hospital, London, UK. European Urology Supplements 2017 16, 149-162DOI: (10.1016/j.eursup.2016.08.005) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 4 European Urological Association of Urology recommendations for stage-dependent local treatment of penile carcinoma [74]. CO2=carbon dioxide; GR=grade of recommendation; LE=level of evidence; Nd:YAG=neodymium:yttrium-aluminium-garnet. European Urology Supplements 2017 16, 149-162DOI: (10.1016/j.eursup.2016.08.005) Copyright © 2016 European Association of Urology Terms and Conditions